Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |